Pleomorphic T-cell lymphoma: Difference between revisions
CSV import |
No edit summary |
||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 13:09, 18 March 2025
Pleomorphic T-cell lymphoma is a type of non-Hodgkin lymphoma that affects the T cells in the immune system. It is characterized by a diverse range of cell shapes and sizes, hence the term "pleomorphic". This lymphoma is considered a subtype of peripheral T-cell lymphoma, which is a group of rare and aggressive lymphomas that develop from mature T cells.
Symptoms
The symptoms of pleomorphic T-cell lymphoma can vary widely, but may include fever, night sweats, weight loss, and fatigue. Swollen lymph nodes are also a common symptom.
Diagnosis
Diagnosis of pleomorphic T-cell lymphoma typically involves a biopsy of an affected lymph node or other tissue. The biopsy sample is then examined under a microscope to identify the presence of abnormal T cells. Other tests, such as blood tests, imaging tests, and a bone marrow biopsy, may also be used to help confirm the diagnosis and determine the extent of the disease.
Treatment
Treatment for pleomorphic T-cell lymphoma often involves chemotherapy, with or without radiation therapy. In some cases, a stem cell transplant may be considered. The choice of treatment depends on a number of factors, including the patient's overall health, the stage of the disease, and the patient's personal preferences.
Prognosis
The prognosis for pleomorphic T-cell lymphoma can vary widely, depending on factors such as the patient's age, overall health, and the stage of the disease at diagnosis. In general, however, this type of lymphoma is considered to be aggressive and difficult to treat.
